Trial Profile
The preventive effect for new vertebral fractures of zoledronic acid and denosumab combined with vitamin D in patients with rheumatoid arthritis.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Jan 2018
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis; Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms EVIDENCE study
- 17 Jan 2018 New trial record